ArticleJournal of clinical orthopaedics and trauma2026
Comparative efficacy of acute targeted muscle reinnervation after upper vs. lower limb amputation: A retrospective, global analysis.
Article in Journal of clinical orthopaedics and trauma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: While targeted muscle reinnervation (TMR) has demonstrated efficacy in reducing chronic pain and symptomatic neuroma formation following limb amputation, differences in outcomes between upper- and lower-limb TMR remain poorly defined. This study compared the efficacy of acute TMR in pain reduction following major upper-versus lower-limb amputation. Methods: A retrospective cohort analysis was conducted using the TriNetX Global Network to identify adults undergoing acute TMR following upper-limb (UL cohort) and lower-limb (LL cohort) amputation. Propensity score matching was performed using demographic and comorbidity covariates. One-year outcomes included new-onset phantom limb pain (PLP), residual limb pain, symptomatic neuroma formation, opioid and neuropathic medication prescriptions, and stump complications. Results: A total of 811 patients met inclusion criteria, with 182 well-matched patients in each cohort. The UL cohort experienced significantly lower rates of PLP (27.5% vs. 40.1%; RR 0.69 [95% CI 0.51-0.92]) and opioid use (59.9% vs. 74.7%; RR 0.80 [95% CI 0.69-0.93]), as well as fewer stump complications (19.8% vs. 34.1%; RR 0.58 [95% CI 0.41-0.83]). RLP (9.9% vs. 7.1%; p = 0.3478) and neuropathic medication use (56.6% vs. 66.5%; p = 0.0525) were similar between cohorts. Conclusions: Acute TMR is associated with significantly lower rates of PLP, opioid use, and stump complications following UL amputation compared with LL amputation. These findings highlight differences in postoperative pain trajectories across patient populations and underscore the need for prospective studies to explore the mechanisms driving these patterns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.